亚太宏基因组学市场至 2027 年 - 按产品(仪器、软件和消耗品)、应用(临床诊断、药物发现宏基因组学等)和国家/地区进行区域分析和预测

Historic Data: 2016-2017   |   Base Year: 2018   |   Forecast Period: 2019-2027


No. of Pages: 141    |    Report Code: TIPRE00003320    |    Category: Life Sciences

Asia Pacific Metagenomics Market

亚太地区宏基因组市场预计将从 2018 年的 3060 万美元增至 2027 年的 6190 万美元。预计 2018 年至 2027 年该市场的复合年增长率为 8.5%。



市场的增长是由基因组学需求不断增长、宏基因组学相对于传统方法的需求不断增长以及宏基因组学的各种应用等因素推动的。亚太地区。然而,昂贵的宏基因组学技术可能会对未来几年市场的增长产生负面影响。

在亚太地区,政府正在为以下领域提供更多支持:基因组学,在政府的支持下,中国企业正在加大对基因研究的投资。由于对基因测序的需求不断增加,该地区的基因组学正在蓬勃发展。亚洲基因组学市场的增长是由老年人口增加、医疗保健系统显着增长和人口收入增加等因素推动的。中国政府强制要求其公民建立数据银行,人口数据包括人民的基因组数据。此外,中国遗传学领头羊华大基因提供的数据显示,2012年至2016年间,中国基因检测市场规模增长了五倍,市场份额约为9250亿美元。此外,近330家预计到 2025 年,65 岁及以上的人口将达到 100 万人,因此个性化医疗的兴起预计将在未来扩大市场。此外,基因组学领域的投资也在不断增加,例如,2016年,中国科学院启动了精准医疗倡议。而它投资了约 90 亿美元用于一个项目,该项目将在 2030 年对超过 1 亿个人类基因组进行测序。最近在 2017 年 12 月,中国科学技术部加入了一个人类基因组研究项目,以记录人类基因组的基因组成25,000 人。

由于市场领导者对基因组学的需求不断增长,使得能够获得宏基因组学研究,可能会推动预测期内市场的增长。

预计在预测期内,中国将引领整个亚太地区宏基因组学的采用。由于宏基因组学的广泛开展,预计中国宏基因组市场在预测期内将出现显着增长。例如。一个名为“从中国云南省分离的蚊子病毒组中黄病毒科的宏基因组分析揭示了登革热和寨卡病毒的基因”的项目进行了。该项目得到了国家重点攻关项目、农业科学研究公益专项基金、国家自然科学基金委等单位的资助。该项目利用 Illumina 测序得出结果。

图表:亚太地区其他地区宏基因组市场收入和 2027 年预测(百万美元)< br />



亚太地区宏基因组学 - 市场细分

按产品


•仪器仪表软件
•耗材

亚太地区宏基因组学 - 市场细分


按应用< /strong>
•临床诊断
•药物发现

按国家


•中国
•印度
•日本

提及的公司


•默克公司
•赛默飞世尔科技公司
•安捷伦科技
• Qiagen
• Bio-Rad Laboratories, Inc.
• Perkinelmer Inc.
• Illumina Inc.
• F Hoffman-La Roche Ltd.
•牛津纳米孔技术有限公司
•加利福尼亚太平洋生物科学公司

Asia Pacific Metagenomics Strategic Insights

Strategic insights for Asia Pacific Metagenomics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-metagenomics-market-strategic-framework.webp
Get more information on this report

Asia Pacific Metagenomics Report Scope

Report Attribute Details
Market size in 2018 US$ 30.6 Million
Market Size by 2027 US$ 61.9 Million
Global CAGR (2018 - 2027) 8.5%
Historical Data 2016-2017
Forecast period 2019-2027
Segments Covered By 产品
  • 仪器
  • 软件和耗材
By 应用
  • 临床诊断
  • 药物发现宏基因组学
Regions and Countries Covered 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
Market leaders and key company profiles
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies
  • Qiagen
  • Bio-Rad Laboratories, Inc.
  • Perkinelmer Inc.
  • Illumina Inc.
  • F Hoffman-La Roche Ltd.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Bioscience of California, Inc.
  • Get more information on this report

    Asia Pacific Metagenomics Regional Insights

    The regional scope of Asia Pacific Metagenomics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-metagenomics-market-geography.webp
    Get more information on this report

    The List of Companies - Asia Pacific Metagenomics Market

    The List of Companies

    1. Merck KGaA
    2. Thermo Fisher Scientific Inc.
    3. Agilent Technologies
    4. Qiagen
    5. Bio-Rad Laboratories, Inc.
    6. Perkinelmer Inc.
    7. Illumina Inc.
    8. F Hoffman-La Roche Ltd.
    9. Oxford Nanopore Technologies Ltd.
    10. Pacific Bioscience of California, Inc.
    Frequently Asked Questions
    How big is the Asia Pacific Metagenomics Market?

    The Asia Pacific Metagenomics Market is valued at US$ 30.6 Million in 2018, it is projected to reach US$ 61.9 Million by 2027.

    What is the CAGR for Asia Pacific Metagenomics Market by (2018 - 2027)?

    As per our report Asia Pacific Metagenomics Market, the market size is valued at US$ 30.6 Million in 2018, projecting it to reach US$ 61.9 Million by 2027. This translates to a CAGR of approximately 8.5% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Metagenomics Market report typically cover these key segments-

  • 产品 (仪器, 软件和耗材)
  • 应用 (临床诊断, 药物发现宏基因组学)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Metagenomics Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Metagenomics Market report:

  • Historic Period : 2016-2017
  • Base Year : 2018
  • Forecast Period : 2019-2027
  • Who are the major players in Asia Pacific Metagenomics Market?

    The Asia Pacific Metagenomics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies
  • Qiagen
  • Bio-Rad Laboratories, Inc.
  • Perkinelmer Inc.
  • Illumina Inc.
  • F Hoffman-La Roche Ltd.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Bioscience of California, Inc.
  • Who should buy this report?

    The Asia Pacific Metagenomics Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Metagenomics Market value chain can benefit from the information contained in a comprehensive market report.